Search Within

Lindsey Elizabeth Roeker

Formats
  1. Meeting Abstract (82)
  2. Journal Article (43)
  3. Research Letter (11)
  4. Review (5)
  5. Editorial (4)
  6. Book Section (1)
Groups
  1. Department of Medicine (146)
  2. Hematologic Malignancies, Division of (146)
  3. Hematology-Oncology Fellows (146)
  4. Center for Hematologic Malignancies (108)
  5. Adult Leukemia (104)
  6. GME, Medicine (43)

More Groups

People
  1. Anthony Mato (94)
  2. Meghan Thompson (37)
  3. Andrew Zelenetz (34)
  4. Omar Abdel-Wahab (16)
  5. Mark Geyer (15)
  6. Colleen Dorsey (14)

More People

Years
  1. 2025 (15)
  2. 2024 (20)
  3. 2023 (24)
  4. 2022 (24)
  5. 2021 (21)
  6. 2020 (21)

More Years

Publications
  1. Blood (58)
  2. Leukemia and Lymphoma (11)
  3. British Journal of Haematology (8)
  4. Blood Advances (7)
  5. Clinical Lymphoma, Myeloma and Leukemia (7)
  6. Journal of Clinical Oncology (7)

More Publications

Publishers
  1. American Society of Hematology (66)
  2. Taylor & Francis Group (11)
  3. Elsevier Inc. (8)
  4. John Wiley & Sons (8)
  5. American Society of Clinical Oncology (7)
  6. S. Karger AG (7)

More Publishers

Results (146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world treatment patterns among a contemporary cohort of commercially insured mantle cell lymphoma patients in the United States
    Meeting Abstract

    Roeker, L. E.; Kabadi, S.; Burudpakdee, C.; Near, A.; Wada, K.; Mato, A. R.
    Blood (2018)

    Fulltext@MSK | Save
  • Venetoclax as monotherapy or in combination: Patterns of use and predictors of outcomes in an international multicenter study of CLL patients
    Meeting Abstract

    Mato, A. R.; Roeker, L. E.; Eyre, T. A.; Nabhan, C.; Lamanna, N.; Hill, B. T.; Brander, D. M.; Barr, P.; Lansigan, F.; Cheson, B.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes of patients with CLL treated with chemoimmuno- and novel agent-based therapy: A multicenter study
    Meeting Abstract

    Mato, A. R.; Yazdy, M. S.; Hill, B. T.; Shadman, M.; Tuncer, H.; Winter, A. M.; Kennard, K.; Allan, J. N.; Ujjani, C. S.; Brander, D. M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Evidence for and against green tea and turmeric in the management of chronic lymphocytic leukemia
    Journal Article

    Bange, E.; Timlin, C.; Kabel, C.; Svoboda, J.; Roeker, L.; Mato, A. R.
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save
  • Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial
    Journal Article

    Mato, A. R.; Roeker, L. E.; Allan, J. N.; Pagel, J. M.; Brander, D. M.; Hill, B. T.; Cheson, B. D.; Furman, R. R.; Lamanna, N.; Tam, C. S.; more...
    American Journal of Hematology (2018)

    Fulltext@MSK | Save
  • Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States
    Journal Article

    Mato, A. R.; Thompson, M.; Allan, J. N.; Brander, D. M.; Pagel, J. M.; Ujjani, C. S.; Hill, B. T.; Lamanna, N.; Lansigan, F.; Jacobs, R.; more...
    Haematologica (2018)

    Fulltext@MSK | Save